Genome Editing Market is segmented By Type of Gene Editing Technique (CRISPR-Cas System, TALENs, Meg...
Market Size in USD Bn
CAGR12.8%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 12.8% |
Market Concentration | Medium |
Major Players | CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Beam Therapeutics, Caribou Biosciences and Among Others |
The genome editing market is estimated to be valued at USD 4.40 Bn in 2025 and is expected to reach USD 10.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2032. The increasing prevalence of genetic disorders and cancer along with advancement in genome editing technologies is driving the growth of genome editing market.